Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|2|6|456-461

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.6, 2005-09, pp. : 456-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 6, 2005-09 ,pp. : 451-455

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting NS5B RNA-Dependent RNA Polymerase for Anti-HCV Chemotherapy

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 207-219

Bentham Science Publishers

Access to resources Recommend Favorite

Allosteric Inhibitors of Hepatitis C NS5B RNA-dependent RNA Polymerase°

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 99-110

Bentham Science Publishers

Access to resources Recommend Favorite

NS5B RNA Dependent RNA Polymerase Inhibitors: The Promising Approach to Treat Hepatitis C Virus Infections

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3806-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Topochemical models for predicting the activity of α,γ-diketo acids as inhibitors of the hepatitis c virus NS5B RNA-dependent RNA polymerase

By Bajaj S.   Sambi S.   Madan A.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 12, 2006-12 ,pp. : 650-654

Springer Publishing Company

Access to resources Recommend Favorite